The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
The graph illustrates the number of deaths from cancer in the United States over the period from 1999 to 2023. The x-axis represents the years, labeled with two-digit abbreviations from '99 to '23, while the y-axis displays the annual number of cancer-related deaths. Throughout this 25-year span, the number of deaths ranges from a minimum of 549,829 in 1999 to a maximum of 613,349 in 2023. The data shows a gradual increase in annual deaths over the years. Notably, the number surpassed 550,000 in 2000 with 553,080 deaths, reached 574,738 in 2010, and exceeded 600,000 in 2020 with 602,347 deaths. The figures continued to rise, culminating in the highest recorded number of 613,349 deaths in 2023.
In 2025, it was estimated that there would be over 972 thousand new cancer cases among women in the United States. This statistic illustrates the estimated number of new cancer cases and deaths in the United States for 2025, by gender.
Cancer was responsible for around *** deaths per 100,000 population in the United States in 2023. The death rate for cancer has steadily decreased since the 1990’s, but cancer still remains the second leading cause of death in the United States. The deadliest type of cancer for both men and women is cancer of the lung and bronchus which will account for an estimated ****** deaths among men alone in 2025. Probability of surviving Survival rates for cancer vary significantly depending on the type of cancer. The cancers with the highest rates of survival include cancers of the thyroid, prostate, and testis, with five-year survival rates as high as ** percent for thyroid cancer. The cancers with the lowest five-year survival rates include cancers of the pancreas, liver, and esophagus. Risk factors It is difficult to determine why one person develops cancer while another does not, but certain risk factors have been shown to increase a person’s chance of developing cancer. For example, cigarette smoking has been proven to increase the risk of developing various cancers. In fact, around ** percent of cancers of the lung, bronchus and trachea among adults aged 30 years and older can be attributed to cigarette smoking. Other modifiable risk factors for cancer include being obese, drinking alcohol, and sun exposure.
Attribution-ShareAlike 4.0 (CC BY-SA 4.0)https://creativecommons.org/licenses/by-sa/4.0/
License information was derived automatically
The graph displays cancer mortality rates by gender in the United States from 1999 to 2023. The x-axis represents the years, labeled from '99 to '23, while the y-axis indicates the mortality rates per 100,000 population for males, females, and the total population. Over this 24-year span, male mortality rates declined from a high of 252.8 in 1999 to a low of 165.4 in 2023. Female mortality rates decreased from 167.2 in 1999 to 123.6 in 2023. The total mortality rate dropped from 200.7 in 1999 to 141.5 in 2023. The data shows a consistent downward trend in cancer mortality rates for both genders and overall. The graph is presented in a line chart format, highlighting the yearly changes and trends in cancer mortality by gender.
Breast cancer was the cancer type with the highest rate of death among females worldwide in 2022. That year, there were around 13 deaths from breast cancer among females per 100,000 population. The death rate for all cancers among females was 76.4 per 100,000 population. This statistic displays the rate of cancer deaths among females worldwide in 2022, by type of cancer.
Open Government Licence - Canada 2.0https://open.canada.ca/en/open-government-licence-canada
License information was derived automatically
Annual percent change and average annual percent change in age-standardized cancer mortality rates since 1984 to the most recent data year. The table includes a selection of commonly diagnosed invasive cancers and causes of death are defined based on the World Health Organization International Classification of Diseases, ninth revision (ICD-9) from 1984 to 1999 and on its tenth revision (ICD-10) from 2000 to the most recent year.
In the period between 2018 and 2022, there were approximately 179 cancer deaths per 100,000 white males in the United States. This statistic shows cancer death rates in the United States for the period 2018-2022, by ethnic group and gender.
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Age-standardised rate of mortality from oral cancer (ICD-10 codes C00-C14) in persons of all ages and sexes per 100,000 population.RationaleOver the last decade in the UK (between 2003-2005 and 2012-2014), oral cancer mortality rates have increased by 20% for males and 19% for females1Five year survival rates are 56%. Most oral cancers are triggered by tobacco and alcohol, which together account for 75% of cases2. Cigarette smoking is associated with an increased risk of the more common forms of oral cancer. The risk among cigarette smokers is estimated to be 10 times that for non-smokers. More intense use of tobacco increases the risk, while ceasing to smoke for 10 years or more reduces it to almost the same as that of non-smokers3. Oral cancer mortality rates can be used in conjunction with registration data to inform service planning as well as comparing survival rates across areas of England to assess the impact of public health prevention policies such as smoking cessation.References:(1) Cancer Research Campaign. Cancer Statistics: Oral – UK. London: CRC, 2000.(2) Blot WJ, McLaughlin JK, Winn DM et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 1988; 48: 3282-7. (3) La Vecchia C, Tavani A, Franceschi S et al. Epidemiology and prevention of oral cancer. Oral Oncology 1997; 33: 302-12.Definition of numeratorAll cancer mortality for lip, oral cavity and pharynx (ICD-10 C00-C14) in the respective calendar years aggregated into quinary age bands (0-4, 5-9,…, 85-89, 90+). This does not include secondary cancers or recurrences. Data are reported according to the calendar year in which the cancer was diagnosed.Counts of deaths for years up to and including 2019 have been adjusted where needed to take account of the MUSE ICD-10 coding change introduced in 2020. Detailed guidance on the MUSE implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/causeofdeathcodinginmortalitystatisticssoftwarechanges/january2020Counts of deaths for years up to and including 2013 have been double adjusted by applying comparability ratios from both the IRIS coding change and the MUSE coding change where needed to take account of both the MUSE ICD-10 coding change and the IRIS ICD-10 coding change introduced in 2014. The detailed guidance on the IRIS implementation is available at: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/bulletins/impactoftheimplementationofirissoftwareforicd10causeofdeathcodingonmortalitystatisticsenglandandwales/2014-08-08Counts of deaths for years up to and including 2010 have been triple adjusted by applying comparability ratios from the 2011 coding change, the IRIS coding change and the MUSE coding change where needed to take account of the MUSE ICD-10 coding change, the IRIS ICD-10 coding change and the ICD-10 coding change introduced in 2011. The detailed guidance on the 2011 implementation is available at https://webarchive.nationalarchives.gov.uk/ukgwa/20160108084125/http://www.ons.gov.uk/ons/guide-method/classifications/international-standard-classifications/icd-10-for-mortality/comparability-ratios/index.htmlDefinition of denominatorPopulation-years (aggregated populations for the three years) for people of all ages, aggregated into quinary age bands (0-4, 5-9, …, 85-89, 90+)
This topic compares cancer mortality rates by race/ethnicity and sex.
Decrease the cancer death rate from 185.7 per 100,000 in 2013 to 180.3 per 100,000 by 2019.
https://creativecommons.org/publicdomain/zero/1.0/https://creativecommons.org/publicdomain/zero/1.0/
In this dataset you'll find tons of different stats on cancer across the United States of America.
This data comes from https://data.world/dartmouthatlas/cancer-patients-death.
https://digital.nhs.uk/about-nhs-digital/terms-and-conditionshttps://digital.nhs.uk/about-nhs-digital/terms-and-conditions
This publication reports on newly diagnosed cancers registered in England during 2022. It includes this summary report showing key findings, spreadsheet tables with more detailed estimates, and a methodology document. Cancer registration estimates are provided for: • Incidence of cancer using groupings that incorporate both the location and type of cancer by combinations of gender, age, deprivation, and stage at diagnosis (where appropriate) for England, former Government office regions, Cancer alliances and Integrated care boards • Incidence and mortality (using ICD-10 3-digit codes) by gender and age group for England, former Government office regions, Cancer alliances and Integrated care boards This publication will report on 2022 cancer registrations only, trends will not be reported as the required re-stated populations for 2012 to 2020 are not expected to be published by the Office of National Statistics (ONS) until Winter 2024.
https://media.market.us/privacy-policyhttps://media.market.us/privacy-policy
(Source: WHO, American Cancer Society)
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Commentary, charts and tables present information on cancer cases and deaths in the UK. This publication has been discontinued as a result of the ONS Consultation on Statistical Products 2013. The last edition published was in December 2012. Source agency: Office for National Statistics Designation: National Statistics Language: English Alternative title: Cancer incidence and mortality
This is historical data. The update frequency has been set to "Static Data" and is here for historic value. Updated on 8/14/2024 Cancer Mortality Rate - This indicator shows the age-adjusted mortality rate from cancer (per 100,000 population). Maryland’s age adjusted cancer mortality rate is higher than the US cancer mortality rate. Cancer impacts people across all population groups, however wide racial disparities exist. Link to Data Details
Open Government Licence 3.0http://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/
License information was derived automatically
Annual data and 5 year summaries of deaths from cancer in Scotland. Data is presented by Cancer Network Region and Health Board; within Scotland and Network levels of reporting, the mortality figures are further broken down by age group and sex. The cancer sites reported on include: bladder, bone and connective tissue, brain and central nervous system, breast colorectal, female genital organs, head and neck, hodgkin lymphoma, kidney, leukaemias, liver, lung and mesothelioma, male genital organs, multiple myeloma, non-hodgkin lymphoma, oesophageal, pancreatic, skin, stomach. Further information on cancer incidence can be found in the annual publication. All publications and supporting material to this topic area can be found on the ISD Scotland Website.
https://www.krebsdaten.de/Krebs/EN/Database/databasequery_step1_node.htmlhttps://www.krebsdaten.de/Krebs/EN/Database/databasequery_step1_node.html
The German Centre for Cancer Registry Data (ZfKD) provides the topical cancer statistics for Germany. In an interactive database query you will get information on incidence and mortality rates as well as for prevalence and survival rates for different types of cancer.
https://market.biz/privacy-policyhttps://market.biz/privacy-policy
Introduction
Cancer Statistics: Cancer continues to pose a major global health challenge, ranking among the top causes of mortality and disease burden worldwide. New cancer cases are rising steadily, influenced by factors such as an aging population, changing lifestyles, and environmental factors. Reliable and current cancer data are essential for comprehending the disease's scale, shaping public health strategies, optimizing resource distribution, and driving scientific research.
These statistics provide a comprehensive overview of recent global cancer incidence, mortality, and survival trends, emphasizing prominent cancer types and geographical differences. Through this analysis, policymakers and healthcare professionals can better focus efforts on prevention, early diagnosis, and treatment to lessen Cancer's impact on communities globally.
Lung cancer is the deadliest cancer worldwide, accounting for 1.82 million deaths in 2022. The second most deadly form of cancer is colorectum cancer, followed by liver cancer. However, lung cancer is only the sixth leading cause of death worldwide, with heart disease and stroke accounting for the highest share of deaths. Male vs. female cases Given that lung cancer causes the highest number of cancer deaths worldwide, it may be unsurprising to learn that lung cancer is the most common form of new cancer cases among males. However, among females, breast cancer is by far the most common form of new cancer cases. In fact, breast cancer is the most prevalent cancer worldwide, followed by prostate cancer. Prostate cancer is a very close second to lung cancer among the cancers with the highest rates of new cases among men. Male vs. female deaths Lung cancer is by far the deadliest form of cancer among males but is the second deadliest form of cancer among females. Breast cancer, the most prevalent form of cancer among females worldwide, is also the deadliest form of cancer among females. Although prostate cancer is the second most prevalent cancer among men, it is the fifth deadliest cancer. Lung, liver, stomach, colorectum, and oesophagus cancers all have higher deaths rates among males.
The United States Cancer Statistics (USCS) online databases in WONDER provide cancer incidence and mortality data for the United States for the years since 1999, by year, state and metropolitan areas (MSA), age group, race, ethnicity, sex, childhood cancer classifications and cancer site. Report case counts, deaths, crude and age-adjusted incidence and death rates, and 95% confidence intervals for rates. The USCS data are the official federal statistics on cancer incidence from registries having high-quality data and cancer mortality statistics for 50 states and the District of Columbia. USCS are produced by the Centers for Disease Control and Prevention (CDC) and the National Cancer Institute (NCI), in collaboration with the North American Association of Central Cancer Registries (NAACCR). Mortality data are provided by the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS), National Vital Statistics System (NVSS).